C. difficile

(Clostridioides difficile)

C. difficile continues to be a leading cause of nosocomial antibiotic-associated diarrhea, prompting the need for earlier and more precise detection. Fast and accurate PCR testing with the GeneXpert® system provides standardised, on-demand and actionable results for better patient management. That’s the PCRplus advantage.

Challenge

Too Many Patients, Not Enough Isolation Beds

Solution

Fast & Accurate PCR Testing for C. difficile in Around 45 Minutes

Learn More

* Following C. difficile sampling guidance detailed in: McDonald L, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Apr;66(7):e1–e48.

1 Carroll K & Mizusawa M. Laboratory tests for the diagnosis of Clostridium difficile. Clin Colon Rectal Surg. 2020 Mar;33(2):73-81.

2 Casari E, et al. Reducing rates of C. difficile infection by switching to a stand-alone NAAT with clear sampling criteria. Antimicrob Resist Infect Control. 2018 Mar;7(40).

3 Peppard W, et al. Implementation of polymerase chain reaction to rule out C. difficile infection is associated with reduced empiric antibiotic duration of therapy. Hosp Pharm. 2014 Jul;49(7):639-43.

CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.